FDA ANDA · ANDA065446

PIPERACILLIN AND TAZOBACTAM

Sponsor: HOSPIRA INC

APPLICATION

ANDA065446

TYPE

ANDA

ORIGINAL APPROVAL

2009-09-15

LATEST ACTION

2017-12-04

ROUTE

INJECTION

DOSAGE FORM

INJECTABLE

MARKETING STATUS

Discontinued

Products

PIPERACILLIN AND TAZOBACTAMDiscontinued

PIPERACILLIN SODIUM EQ 36GM BASE/VIAL, TAZOBACTAM SODIUM EQ 4.5GM BASE/VIAL · INJECTABLE · INJECTION

2017-12-04Labeling · Supplement 14 · standardAP

2017-12-04Labeling · Supplement 10 · standardAP

2017-12-04Labeling · Supplement 7 · standardAP

2017-12-04Labeling · Supplement 3AP

2017-12-04Labeling · Supplement 13 · standardAP

2017-12-04Labeling · Supplement 11 · standardAP

2009-09-15Original — Letter ↗AP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.